The Microbiome Congress in May in Rotterdam brought together three conferences: the 6th Microbiome forum, the 3rd Probiotics Congress and the Skin Microbiome and Cosmeceuticals congress, running in parallel. For this reason this report can’t […]
Genetics has a greater impact on the microbiome than maternal birth environment, at least in mice, according to a study published this week in Applied and Environmental Microbiology. Vaginal birth, known to transfer microbiota to […]
A research team led by Tufts University engineers has developed a 3D printed pill that samples bacteria found in the gut — known as the microbiome — as it passes through the gastrointestinal tract (GI). […]
Getting up close – and a little dirty – with farm animals just might help us fend off illness, say researchers who’ve further demonstrated the benefits of early exposure to a wide variety of environmental […]
Ilya Pharma developing advanced biologics announced that a first in human trial for its lead candidate ILP100 has been approved by the Swedish Medical Products Agency. ILP100 is based on genetically engineered lactic acid bacteria […]
Pherecydes Pharma and BIOASTER, the French Technology Research Institute (TRI) for Microbiology and Infectious Diseases, announced the signing of a collaboration agreement. This project, called PhagUTI, is a unique opportunity for the partners to capitalize […]
Chardan Healthcare Acquisition Corp. (NYSE: CHAC, “CHAC”), a special purpose acquisition company (“SPAC”) sponsored by affiliates of Chardan Capital Markets LLC (“Chardan”), announced today that it has entered into a definitive agreement for a business […]
TargEDys announces that BIOCODEX has acquired a share of its capital and appoints new board members. Biocodex is an independent multinational pharmaceutical company built on high-standard science and manufacturing, with six decades of proven success. Founded in […]
Synlogic, Inc., (Nasdaq: SYBX), a clinical stage company developing a novel class of Synthetic BioticTM therapeutics, announced positive top-line clinical data from patient cohorts of a randomized, double-blind, placebo-controlled Phase 1/2a study of SYNB1618, which […]
Philosopher Nicolae Morar was perplexed by various metaphors tossed about by scientists studying the human microbiome. Microbiologist Brendan Bohannan was sure that thinking of the human body as an ecosystem correctly framed the research being […]
A multicentre Phase I/II double-blind, placebo-controlled study of MRx-4DP0004 in patients with poorly controlled asthma has now commenced. The study will enrol 90 asthma patients not adequately controlled on their current inhaler maintenance therapy. Patients […]